April 2026 FDA Recall Drug by Wisconsin Pharmacal Company
D-0553-2026 - Microbial Contamination of Non-Sterile Products

This Class I drug recall was voluntarily initiated by Wisconsin Pharmacal Company on April 24, 2026 for the product Drug. The FDA reported the reason for recall as microbial contamination of non-sterile products. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0553-2026

Reason for Recall
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Initiated
04-24-2026
Reported
05-27-2026
Quantity
690 tubes

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
98788
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Wisconsin Pharmacal Company
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
USA Nationwide and Bahamas
Product Description About Product Description
Full technical description of the product.
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.

Batch or Lot Expiration Information

Lot# : 1024088, Exp 11/30/2026